Cite Filings / EDIT
Feed Companies Filings Check
Sign in

CIK 0001650664 · Non-accelerated filer<br>Smaller reporting company

Editas Medicine, Inc.

Sign in to watch
Ticker
EDIT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464097528
Phone
617-401-9000
Business address
11 HURLEY ST., CAMBRIDGE, MA, 02141
Filings Insiders Search text
All 731 Financials 178 Shareholder Meetings 11 Executive Compensation 154 Insider Trading 349 Beneficial Ownership Interest 78 Business Combinations 133 Public Offerings 36 Mutual Funds and ETFs 10 Others 89
›
Filed in
  1. No filings match these filters. Clear filters
  2. DEF 14A Proxy Proxy Statement 2026-04-28
  3. DEF 14A Proxy Proxy Statement 2025-04-15
  4. PRE 14A Proxy Proxy Statement (Preliminary) 2025-04-04
  5. DEF 14A Proxy Proxy Statement 2024-04-16
  6. DEF 14A Proxy Proxy Statement 2023-04-18
  7. DEF 14A Proxy Proxy Statement 2022-04-26
  8. DEF 14A Proxy Proxy Statement 2021-04-20
  9. DEF 14A Proxy Proxy Statement 2020-04-28
  10. DEF 14A Proxy Proxy Statement 2019-04-26
  11. DEF 14A Proxy Proxy Statement 2018-04-27
  12. DEF 14A Proxy Proxy Statement 2017-04-26

Page 1 of 1 · 11 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…